Invention Grant
- Patent Title: Ammonium derivatives for the treatment of hepatitis C
-
Application No.: US14762537Application Date: 2014-01-23
-
Publication No.: US09918988B2Publication Date: 2018-03-20
- Inventor: Tao Wang , Zhiwei Yin , Zhongxing Zhang , Paul Michael Scola
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent John F. Levis
- International Application: PCT/US2014/012634 WO 20140123
- International Announcement: WO2014/116766 WO 20140731
- Main IPC: C07D251/52
- IPC: C07D251/52 ; C07D498/10 ; A61K31/53 ; C07D498/08 ; A61K45/06 ; A61K38/13 ; A61K38/20 ; A61K38/21
Abstract:
Compounds of Formula I, including pharmaceutically acceptable salts thereof, are set forth, in addition to compositions and methods of using these compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Public/Granted literature
- US20150322085A1 AMMONIUM DERIVATIVES FOR THE TREATMENT OF HEPATITIS C Public/Granted day:2015-11-12
Information query
